Capital Fund Management (CFM)’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 950 |
|
|
2025
Q1 | – | Sell |
-18,097
| Closed | -$712K | – | 875 |
|
|
2024
Q4 | $712K | Sell |
18,097
-32,007
| -64% | -$1.26M | ﹤0.01% | 705 |
|
|
2024
Q3 | $2.35M | Buy |
+50,104
| New | +$2.35M | 0.01% | 486 |
|
|
2024
Q2 | – | Sell |
-56,114
| Closed | -$3.82M | – | 735 |
|
|
2024
Q1 | $3.82M | Sell |
56,114
-16,905
| -23% | -$1.15M | 0.01% | 368 |
|
|
2023
Q4 | $4.57M | Buy |
+73,019
| New | +$4.57M | 0.01% | 365 |
|
|
2023
Q3 | – | Sell |
-42,026
| Closed | -$2.36M | – | 722 |
|
|
2023
Q2 | $2.36M | Buy |
42,026
+29,785
| +243% | +$1.67M | 0.01% | 390 |
|
|
2023
Q1 | $554K | Sell |
12,241
-48,013
| -80% | -$2.17M | ﹤0.01% | 496 |
|
|
2022
Q4 | $2.45M | Buy |
+60,254
| New | +$2.45M | 0.02% | 321 |
|
|
2022
Q3 | – | Sell |
-104,142
| Closed | -$6.33M | – | 630 |
|
|
2022
Q2 | $6.33M | Sell |
104,142
-114,730
| -52% | -$6.97M | 0.06% | 167 |
|
|
2022
Q1 | $13.7M | Buy |
218,872
+129,831
| +146% | +$8.15M | 0.11% | 69 |
|
|
2021
Q4 | $6.75M | Sell |
89,041
-36,926
| -29% | -$2.8M | 0.05% | 161 |
|
|
2021
Q3 | $14.1M | Buy |
125,967
+111,461
| +768% | +$12.5M | 0.1% | 78 |
|
|
2021
Q2 | $2.35M | Sell |
14,506
-6,397
| -31% | -$1.04M | 0.02% | 317 |
|
|
2021
Q1 | $2.55M | Buy |
+20,903
| New | +$2.55M | 0.03% | 258 |
|
|
2020
Q4 | – | Sell |
-10,858
| Closed | -$908K | – | 622 |
|
|
2020
Q3 | $908K | Buy |
+10,858
| New | +$908K | 0.01% | 399 |
|
|
2020
Q2 | – | Sell |
-7,035
| Closed | -$298K | – | 615 |
|
|
2020
Q1 | $298K | Buy |
7,035
+3,565
| +103% | +$151K | ﹤0.01% | 647 |
|
|
2019
Q4 | $211K | Buy |
+3,470
| New | +$211K | ﹤0.01% | 831 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 849 |
|
|
2018
Q4 | – | Sell |
-34,040
| Closed | -$1.51M | – | 880 |
|
|
2018
Q3 | $1.51M | Buy |
+34,040
| New | +$1.51M | 0.01% | 521 |
|